INCY
INCYTE CORP
+1.68 (+1.35%)126.43USD284K成交股數25.3B市值17.9本益比(近四季)4.7股價營收比+20.9%營收年增(近四季)2026-10-27下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 32 · 21.1M · 4 |
| 其中 10b5-1 計畫賣出 | 32 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 24.8M |
| 近 180 天 淨額 | −24.8M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | 08-27 | Basi Ramitpal K | EVP, Human Resources | F 繳稅扣股 | 504 | 129.72 | 65K | 11.0K | SEC |
| 2026-08-19 | 08-20 | CAGNONI PABLO J | President, Global Head of R&D | S 公開市場賣出(10b5-1) | 10.8K | 125.56 | 1.4M | 183K | SEC |
| 2026-08-12 | 08-14 | CAGNONI PABLO J | President, Global Head of R&D | S 公開市場賣出(10b5-1) | 10.8K | 120.04 | 1.3M | 194K | SEC |
| 2026-08-05 | 08-07 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.2K | 123.99 | 274K | 61.4K | SEC |
| 2026-08-05 | 08-07 | CAGNONI PABLO J | President, Global Head of R&D | S 公開市場賣出(10b5-1) | 10.6K | 122.69 | 1.3M | 205K | SEC |
| 2026-08-05 | 08-07 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.2K | 106.47 | 235K | 63.6K | SEC |
| 2026-08-03 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 6.1K | 105.43 | 638K | 67.5K | SEC |
| 2026-08-03 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.1K | 120.43 | 729K | 61.4K | SEC |
| 2026-08-03 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 6.1K | 105.43 | 638K | 67.5K | SEC |
| 2026-08-03 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.1K | 120.43 | 729K | 61.4K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.6K | 74.78 | 196K | 88.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.2K | 119.43 | 737K | 75.0K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.9K | 119.40 | 342K | 67.4K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.9K | 77.67 | 222K | 91.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.3K | 119.42 | 637K | 83.3K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 9.5K | 72.27 | 684K | 86.2K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.1K | 71.93 | 149K | 76.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 3.1K | 68.62 | 216K | 74.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 85 | 106.47 | 9K | 103K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.3K | 90.56 | 208K | 103K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 326 | 105.43 | 34K | 103K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 14.7K | 119.46 | 1.8M | 88.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.3K | 90.56 | 208K | 103K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.2K | 119.47 | 261K | 81.2K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 5.3K | 119.42 | 637K | 83.3K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.7K | 119.39 | 561K | 70.3K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.9K | 119.40 | 342K | 67.4K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.6K | 119.51 | 196K | 65.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.6K | 119.38 | 196K | 64.1K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 85 | 122.19 | 10K | 64.1K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.7K | 61.76 | 167K | 71.5K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 1.6K | 85.01 | 140K | 101K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.7K | 61.76 | 167K | 71.5K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.6K | 83.58 | 219K | 99.0K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.3K | 64.25 | 147K | 68.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.3K | 64.25 | 147K | 68.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 3.1K | 68.62 | 216K | 74.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 3.0K | 83.20 | 252K | 96.4K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.1K | 71.93 | 149K | 76.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 9.5K | 72.27 | 684K | 86.2K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.6K | 74.78 | 196K | 88.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.9K | 77.67 | 222K | 91.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 1.6K | 80.50 | 132K | 93.3K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 3.0K | 83.20 | 252K | 96.4K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.6K | 83.58 | 219K | 99.0K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 1.6K | 85.01 | 140K | 101K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.9K | 61.18 | 179K | 66.5K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 85 | 106.47 | 9K | 103K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 326 | 105.43 | 34K | 103K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 14.7K | 119.46 | 1.8M | 88.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 2.9K | 61.18 | 179K | 66.5K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.2K | 119.47 | 261K | 81.2K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.2K | 119.43 | 737K | 75.0K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.7K | 119.39 | 561K | 70.3K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 326 | 121.69 | 40K | 63.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.6K | 119.51 | 196K | 65.8K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 1.6K | 119.38 | 196K | 64.1K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 85 | 122.19 | 10K | 64.1K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 326 | 121.69 | 40K | 63.7K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.3K | 119.41 | 274K | 61.4K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | M 選擇權執行 | 1.6K | 80.50 | 132K | 93.3K | SEC |
| 2026-07-31 | 08-04 | CAGNONI PABLO J | President, Global Head of R&D | S 公開市場賣出(10b5-1) | 15.9K | 119.70 | 1.9M | 215K | SEC |
| 2026-07-31 | 08-04 | Mayes Patrick A | EVP & Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.3K | 119.41 | 274K | 61.4K | SEC |
| 2026-07-16 | 07-20 | Hoffman Richard A. | EVP & General Counsel | A 獲配股票 | 7.4K | – | – | 16.9K | SEC |
| 2026-07-16 | 07-20 | Basi Ramitpal K | EVP, Human Resources | A 獲配股票 | 5.0K | – | – | 11.5K | SEC |
| 2026-07-16 | 07-20 | Stein Steven H | CMO & Head of Late-Stage Dev. | A 獲配股票 | 9.8K | – | – | 30.9K | SEC |
| 2026-07-16 | 07-20 | Stein Steven H | CMO & Head of Late-Stage Dev. | S 公開市場賣出(10b5-1) | 1.9K | 114.73 | 215K | 21.1K | SEC |
| 2026-07-16 | 07-20 | CAGNONI PABLO J | President, Global Head of R&D | A 獲配股票 | 13.4K | – | – | 231K | SEC |
| 2026-07-16 | 07-20 | Meury William | Chief Executive Officer | A 獲配股票 | 26.8K | – | – | 183K | SEC |
| 2026-07-16 | 07-20 | Mayes Patrick A | EVP & Chief Scientific Officer | A 獲配股票 | 5.9K | – | – | 63.6K | SEC |
| 2026-07-16 | 07-20 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | A 獲配股票 | 7.9K | – | – | 71.8K | SEC |
| 2026-07-16 | 07-20 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | S 公開市場賣出(10b5-1) | 1.1K | 115.01 | 126K | 63.9K | SEC |
| 2026-07-16 | 07-20 | Gardner David H | EVP, Chief Strategy Officer | A 獲配股票 | 7.4K | – | – | 16.8K | SEC |
| 2026-07-16 | 07-20 | Tray Thomas | Principal Accounting Officer | A 獲配股票 | 2.8K | – | – | 21.7K | SEC |
| 2026-07-15 | 07-16 | Stein Steven H | CMO & Head of Late-Stage Dev. | S 公開市場賣出(10b5-1) | 28.2K | 113.05 | 3.2M | 26.1K | SEC |
| 2026-07-15 | 07-16 | Mayes Patrick A | EVP & Chief Scientific Officer | F 繳稅扣股 | 1.5K | 115.09 | 174K | 57.7K | SEC |
| 2026-07-15 | 07-16 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | F 繳稅扣股 | 1.1K | 115.09 | 126K | 65.0K | SEC |
| 2026-07-15 | 07-16 | CAGNONI PABLO J | President, Global Head of R&D | F 繳稅扣股 | 5.0K | 115.09 | 570K | 218K | SEC |
| 2026-07-15 | 07-16 | Stein Steven H | CMO & Head of Late-Stage Dev. | F 繳稅扣股 | 3.1K | 115.09 | 355K | 23.0K | SEC |
| 2026-07-15 | 07-16 | Tray Thomas | Principal Accounting Officer | F 繳稅扣股 | 1.1K | 115.09 | 126K | 18.9K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 30.8M | 3.5B | 新進 | 新進 |
| BlackRock, Inc. | 18.0M | 2.0B | 新進 | 新進 |
| Dodge & Cox | 12.0M | 1.4B | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.0M | 1.2B | 新進 | 新進 |
| STATE STREET CORP | 9.7M | 1.1B | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.8M | 883M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 5.3M | 603M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.8M | 537M | 新進 | 新進 |
| Invesco Ltd. | 4.1M | 463M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.6M | 405M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 3.5M | 398M | 新進 | 新進 |
| MORGAN STANLEY | 2.9M | 334M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.7M | 311M | 新進 | 新進 |
| Robeco Institutional Asset Management B.V. | 2.4M | 277M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 2.3M | 261M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 2.3M | 259M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 2.0M | 227M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.8M | 200M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.7M | 192M | 新進 | 新進 |
| Legal & General Group Plc | 1.6M | 182M | 新進 | 新進 |
| FIRST TRUST ADVISORS LP | 1.6M | 180M | 新進 | 新進 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.5M | 171M | 新進 | 新進 |
| VICTORY CAPITAL MANAGEMENT INC | 1.5M | 168M | 新進 | 新進 |
| FMR LLC | 1.4M | 157M | 新進 | 新進 |
| Caisse de depot et placement du Quebec | 1.4M | 155M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 858 +43 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 858 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 203M · 100.0% |
| 合計季末市值 | 21.9B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 9.4M |
|---|---|
| 與上期比 | -0.3% |
| 佔流通股數 | 4.69% |
| 日均成交量 | 1.2M |
| 回補天數 | 7.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 9.4M | -0.3% | 4.69% | 1.2M | 7.7 |
| 2026-08-14 | 9.4M | -8.4% | 4.70% | 1.4M | 6.7 |
| 2026-07-31 | 10.2M | -2.5% | 5.13% | 2.1M | 4.8 |
| 2026-07-15 | 10.5M | -0.6% | 5.26% | 1.6M | 6.5 |
| 2026-06-30 | 10.6M | +0.2% | 5.30% | 2.2M | 4.8 |
| 2026-06-15 | 10.6M | -7.4% | 5.29% | 2.2M | 4.7 |
| 2026-05-29 | 11.4M | +3.3% | 5.71% | 1.2M | 9.2 |
| 2026-05-15 | 11.0M | -2.8% | 5.53% | 1.3M | 8.7 |
| 2026-04-30 | 11.4M | -5.2% | 5.69% | 1.6M | 7.1 |
| 2026-04-15 | 12.0M | +4.6% | 5.99% | 1.2M | 9.8 |
| 2026-03-31 | 11.4M | +3.6% | 5.73% | 1.7M | 6.6 |
| 2026-03-13 | 11.0M | +0.3% | 5.53% | 1.6M | 7.0 |
| 2026-02-27 | 11.0M | +0.0% | 5.51% | 1.6M | 6.8 |
| 2026-02-13 | 11.0M | -1.7% | 5.51% | 2.1M | 5.1 |
| 2026-01-30 | 11.2M | +3.7% | 5.60% | 1.7M | 6.6 |
| 2026-01-15 | 10.8M | +2.4% | 5.40% | 2.4M | 4.6 |
| 2025-12-31 | 10.5M | -2.0% | 5.28% | 1.8M | 5.9 |
| 2025-12-15 | 10.8M | +17.6% | 5.38% | 2.3M | 4.6 |
| 2025-11-28 | 9.1M | -3.6% | 4.58% | 1.9M | 4.9 |
| 2025-11-14 | 9.5M | -0.2% | 4.75% | 2.7M | 3.5 |
| 2025-10-31 | 9.5M | +1.6% | 4.76% | 2.8M | 3.4 |
| 2025-10-15 | 9.4M | +10.1% | 4.69% | 1.5M | 6.2 |
| 2025-09-30 | 8.5M | -2.2% | 4.26% | 1.8M | 4.7 |
| 2025-09-15 | 8.7M | +15.7% | 4.35% | 1.8M | 4.9 |
| 2025-08-29 | 7.5M | -21.8% | 3.76% | 1.5M | 4.9 |
| 2025-08-15 | 9.6M | +29.4% | 4.81% | 1.8M | 5.3 |